miércoles, 3 de marzo de 2021

Covaxin shows interim vaccine efficacy of 81% in Phase 3 trial: Bharat Biotech | India News,The Indian Express

Covaxin shows interim vaccine efficacy of 81% in Phase 3 trial: Bharat Biotech | India News,The Indian Express

No hay comentarios:

Publicar un comentario